Read more

August 04, 2022
6 min watch
Save

VIDEO: ASPC president discusses congress highlights and return to live meetings

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LOUISVILLE, Ky. — In this Healio video exclusive, the president of American Society for Preventive Cardiology discusses the return to an in-person ASPC Congress on CVD Prevention as well as some highlights from the meeting.

ASPC President Martha Gulati, MD, MS, FACC, FAHA, FASPC, who is associate director of the Barbra Streisand Women's Heart Center and director of preventive cardiology at Cedars-Sinai reviewed ASPC presentations about the future of CV prevention; BP control; open artery ischemia; the interaction between heart disease, diabetes and chronic kidney disease; the role of nonalcoholic fatty liver disease in dyslipidemia; and the personalization of hypertension treatment.

Watch the video for more.

References:

  • Arnett D. Personalization of Treatment for Hypertension in Practice Guidelines: The Future (or Not)? Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.
  • Douglas PS. Strengthening CV Prevention for the Future: Beyond the ABCs. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.
  • Levy P. Can We ACHIEVE GREATER Blood Pressure Control? A Novel Model for the Prevention of Cardiovascular Disease. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.
  • Pepine C. Open Artery Ischemia: An unrecognized opportunity for prevention? Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.
  • Rinella M. The Role of NAFLD in the Development and Management of Dyslipidemia. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.
  • Tuttle K. The Cardio-Renal-Metabolic Intersection: Diabetes and Chronic Kidney Disease. Presented at: American Society for Preventive Cardiology Congress on CVD Prevention; July 29-31, 2022; Louisville, Kentucky.